Sofinnova Investments, Inc.
56 holdingsFiling period: 2026-06-30Current AUM: $2.02Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera Inc | 1.55M | $420.8M | $642.3M | 31.80% | -- | 2026-06-30 |
| 2 | VERA | Vera Therapeutics Inc | 2.79M | $119.9M | $86.6M | 4.28% | -- | 2026-06-30 |
| 3 | GMAB | Genmab A/S | 4.05M | $111.1M | $230.8M | 11.43% | +3.29M | 2026-06-30 |
| 4 | — | Jazz Pharmaceuticals PLC | 365.3K | $88.0M | $88.0M | 4.36% | -232,986 | 2026-06-30 |
| 5 | RAPP | Rapport Therapeutics Inc | 1.90M | $79.4M | $47.7M | 2.36% | -- | 2026-06-30 |
| 6 | SPTX | Seaport Therapeutics Inc | 3.56M | $77.4M | $69.9M | 3.46% | -- | 2026-06-30 |
| 7 | RARE | Ultragenyx Pharmaceutical In | 2.22M | $74.0M | $35.7M | 1.77% | -1,278,383 | 2026-06-30 |
| 8 | AVBP | Arrivent BioPharma Inc | 1.70M | $58.9M | $25.2M | 1.25% | -- | 2026-06-30 |
| 9 | BIOA | BioAge Labs Inc | 2.29M | $56.2M | $13.5M | 0.67% | -- | 2026-06-30 |
| 10 | BMY | Bristol-Myers Squibb Co | 877.0K | $50.5M | $54.8M | 2.71% | -1,111,751 | 2026-06-30 |
| 11 | SUPN | Supernus Pharmaceuticals | 1.04M | $48.2M | $43.4M | 2.15% | +82.0K | 2026-06-30 |
| 12 | RYTM | Rhythm Pharmaceuticals Inc | 408.0K | $45.3M | $37.8M | 1.87% | -42,069 | 2026-06-30 |
| 13 | GILD | Gilead Sciences Inc | 343.1K | $43.3M | $58.6M | 2.90% | -- | 2026-06-30 |
| 14 | UTHR | United Therapeutics Corp Del | 76.5K | $41.4M | $45.8M | 2.27% | -163,881 | 2026-06-30 |
| 15 | COGT | Cogent Biosciences Inc | 1.04M | $40.1M | $32.1M | 1.59% | -1,078,403 | 2026-06-30 |
| 16 | AXSM | Axsome Therapeutics Inc. | 160.4K | $39.3M | $23.2M | 1.15% | -252,318 | 2026-06-30 |
| 17 | — | Immatics N.V | 3.67M | $37.2M | $37.2M | 1.84% | +38.9K | 2026-06-30 |
| 18 | DYN | Dyne Therapeutics Inc | 1.66M | $36.8M | $27.7M | 1.37% | +24.5K | 2026-06-30 |
| 19 | IMNM | Immunome Inc | 1.72M | $36.5M | $31.3M | 1.55% | +18.4K | 2026-06-30 |
| 20 | IDYA | IDEAYA Biosciences Inc | 925.1K | $34.5M | $29.6M | 1.46% | -206,667 | 2026-06-30 |
| 21 | ANAB | Anaptysbio Inc | 493.5K | $33.3M | $23.8M | 1.18% | +245.3K | 2026-06-30 |
| 22 | NKTR | Nektar Therapeutics | 471.8K | $32.9M | $18.3M | 0.91% | -37,783 | 2026-06-30 |
| 23 | — | Pharvaris N V | 881.3K | $30.5M | $30.5M | 1.51% | +63.0K | 2026-06-30 |
| 24 | RCUS | Arcus Biosciences Inc | 945.7K | $29.2M | $17.2M | 0.85% | +22.6K | 2026-06-30 |
| 25 | INBX | Inhibrx Biosciences Inc | 303.1K | $28.7M | $21.8M | 1.08% | -102,926 | 2026-06-30 |
← Scroll →
Page 1 of 3